Abstract:Objectives BackgroundSCN5A is encoding human sodium channel protein Nav1.5. Mutations on SCN5A have been found to induce multiple fatal arrhythmia syndromes, such as Long QT syndrome (LQTS), atrioventricular block (AVB) and Brugada syndrome. This study aimed to explore the pathogenic spectrum, characteristics and therapeutic outcomes of the syndromes caused by mutations on SCN5A.MethodsOne LQT3 kindred and an AVB kindred from the Chinese National Channelopathy Registry Study were investigated. Blood samples and clinical data were obtained under written consents. Mutational screening of SCN5A gene was performed via PCR and direct DNA sequence analysis. LQTS or AVB phenotype and therapeutic outcomes were evaluated for all probands and family members. Genotype-phenotype evaluation was also performed for family members. Mutational analyses were based on NCBI standardised mRNA sequence (SCN5A: NM_198056.2).ResultsThe LQTS proband was a 1-year-old girl (test-tube baby). She had her first syncope at 9-month-old in night sleep. Afterwards several episodes of syncope occurred, often accompanied by Torsades de Pointes (TdP) and ventricular fibrillation. ECG showed a maximum QTc of 690ms, while no abnormality was found on ECG of her parents. Gene screening of SCN5A identified a novel mutation F1473S (4418 T>C) on the proband, but this mutation was not detected on the parents, indicating a de novo mutation. Medication with propranolol (2.5 mg/kg/d) alone did not improve the symptoms. Additional use of mexiletine (12.5 mg/kg/d) showed some improvement, but syncopes still occurred now and then. Then the dosage was adjusted to propranolol (2.5 mg/kg/d) and mexilatine (15 mg/kg/d). The girl died at 23-month-old, though the external defibrillator was used at home. The AVB proband is a 57-year-old male. He showed symptoms of bradycardia, short of breath and even inability to lie down. ECG indicated complete right bundle branch block (RBBB) and left anterior fascicular block. He has received pacemaker implantation in March of 2011 and no symptoms occurred since then. A novel mutation F919L (2757C>A) on SCN5A was found. No AVB related symptoms were found on his family members, except for RBBB showed in the ECG of his son and brother. Gene screening detected the same mutation in both persons. To note, the proband9s father had sudden death at age of 57, but no DNA sample is available to determine his genotype.ConclusionsThe present study revealed two novel mutations, F1473S and F919L on SCN5A, which have not been reported. The two novel mutations induced distinct but equally lethal arrhythmia syndromes, LQTS and AVB, respectively. In consider of the reports in western countries of relatively severe LQTS-causing mutation F1473C (4418 T>G) on SCN5A, we may also conclude that the site SCN5A1473 is a mutational “hot spot”, which characterises an early onset and severe phenotype of LQT3.

Clinical Comparison and Functional Study of the L703P: a Recurrent Mutation in Human SCN4A That Causes Sodium Channel Myotonia.

N1366S Mutation of Human Skeletal Muscle Sodium Channel Causes Paramyotonia Congenita

Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.

Diverse biophysical mechanisms in voltage-gated sodium channel Nav1.4 variants associated with myotonia

Enhanced Slow Inactivation of the Human Skeletal Muscle Sodium Channel Causing Normokalemic Periodic Paralysis

Changes in Resurgent Sodium Current Contribute to the Hyperexcitability of Muscles in Patients with Paramyotonia Congenita

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

Clinical, Myopathological Features and Sodium Channel Α-Subunit Encoding Gene Mutation Analysis in 17 Patients with Skeletal Muscle Sodium Channelopathies

[I1363T Mutation Induces the Defects in Fast Inactivation of Human Skeletal Muscle Voltage-Gated Sodium Channel].

A novel muscle sodium channel mutation causes painful congenital myotonia

The R900S Mutation in CACNA1S Associated with Hypokalemic Periodic Paralysis

Clinical and Genetic Spectrum of a Chinese Cohort with SCN4A Gene Mutations

Electromyographic Features in a Chinese Cohort with Hereditary Skeletal Muscle Channelopathies.

EP.132Central Core Myopathy in Chinese Patients with Nav1.4 P.r675q Mutation

Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in SCN4A gene

Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype

Three Novel Mutations of Potassium Channel HERG and SCN5A in Chinese Families of Congenital Long QT Syndromes

NOVEL MUTATIONS ON SCN5A CAUSED FATAL ARRHYTHMIA SYNDROME IN CHINESE

Α-1-syntrophin Mutation and the Long-QT Syndrome

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment

Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in Na V 1.4